Anti-IL-11 antibody therapy decreases levels of IL-11 and pro-inflammatory factors in the lung tissue without shifting the IL-12 – IFN-γ/IL-10 balance.
- Marina A. Kapina (249466)
- Galina S. Shepelkova (348058)
- Vadim G. Avdeenko (348059)
- Anna N. Guseva (348060)
- Tatiana K. Kondratieva (348061)
- Vladimir V. Evstifeev (348062)
- Alexander S. Apt (348063)
Publication date
February 2013
DOIAbstract
<p>Cytokine contents in lung homogenates were assessed by ELISA for 4 mice in each group. The results of one of two similar experiments are displayed as mean ± SEM.</p
Add to ORKG